ARCHIVES

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

This article is from The Cancer Letter archive.

Vol. 18 No. 38 | October 2, 1992

Download PDF Visit The Full Archive

Related Articles

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

NCAB Meeting Moved To October

July 20, 1979

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

In Brief: Peter Jones Is Interim director of USC’s Norris; NIAMS Funds Skin Disease Corse At Yale, Texas

January 1, 1993

Schweiker Approves Chabner Appointment

September 10, 1982

In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship

July 23, 1999